Nuveen Asset Management, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$3,486,000
+0.2%
343,118
+0.2%
0.00%0.0%
Q4 2021$3,479,000
-7.7%
342,455
-7.7%
0.00%0.0%
Q3 2021$3,770,000
-21.9%
371,035
-21.9%
0.00%0.0%
Q2 2021$4,827,000
+14.2%
475,069
+10.9%
0.00%0.0%
Q1 2021$4,225,000
-1.9%
428,495
+7.9%
0.00%0.0%
Q4 2020$4,306,000
+5.6%
397,228
+0.3%
0.00%
-50.0%
Q3 2020$4,079,000
-45.1%
396,011
+11.3%
0.00%
-33.3%
Q2 2020$7,426,000
+207.4%
355,681
+43.8%
0.00%
+200.0%
Q1 2020$2,416,000
-2.6%
247,280
+14.8%
0.00%0.0%
Q4 2019$2,480,000
+115.5%
215,312
+2.0%
0.00%
Q3 2019$1,151,000
-55.0%
211,153
-1.9%
0.00%
-100.0%
Q2 2019$2,559,000215,1620.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,102,735$3,485,0003.61%
VHCP Management II, LLC 280,000$885,0000.53%
GREAT POINT PARTNERS LLC 550,116$1,738,0000.50%
JW Asset Management, LLC 189,919$600,0000.48%
DAFNA Capital Management LLC 140,600$444,0000.35%
Granite Point Capital Management, L.P. 186,544$589,0000.25%
SABBY MANAGEMENT, LLC 779,926$2,465,0000.13%
TFS CAPITAL LLC 159,364$504,0000.09%
Rhenman & Partners Asset Management AB 154,006$487,0000.09%
Numeric Investors LLC 1,134,931$3,586,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders